@MassiveBio

Empowering cancer patients globally through our AI-based, clinical trial matching platform, always 100% free. Providing options & hope.

massivebio.com/
Joined January 2015
  • Tweets7.5K
  • Following1.9K
  • Followers2K
1.9KMedia
Massive Bio retweeted
OncoDaily
@oncodailyAug 5
Massive Bio - Building the Next Generation of AI-Driven Cancer Care with Rivvi AI @MassiveBio @DrArturoAI oncodaily.com/voices/massive…
2
4
296
Another reason why #ASCO26 is so special is how we all come together to find each other for collaborations, research, science, and R&D. Even better when meeting with @ASCO staff, friends, colleagues, mentors and mentees. Hearts are full, science is shared, the best of humanity represented in the fight against cancer (and of course, AI 😉) @mystlukes @MassiveBio
4
11
399
Massive Bio retweeted
500 Global
@500GlobalVCMay 6
As AI reshapes healthcare, one of its most meaningful impacts is breaking down barriers to access — ensuring the right patients can find the right treatments at the right time. @MassiveBio's partnership with @OpenAI is a powerful step in that direction. By transforming complex clinical trial protocols into machine-readable formats, the team is enabling real-time, automated patient pre-screening at scale. "By collaborating with OpenAI, we are transforming how trials are interpreted and operationalized. This is infrastructure-level deployment that can close the gap between the thousands of open trials and the millions of patients who never learn they may qualify." — Co-founder & Chief Medical AI Officer Arturo LoAIza-Bonilla MD. Read the full story: lnkd.in/gBEZAJv2 @christine_tsai @TonyW @vishalharnal @atxfrench @leoclee

LinkedIn

This link will take you to a page that’s not on LinkedIn

lnkd.in
Massive Bio
@MassiveBioApr 30
Replying to @MassiveBio
@MassiveBio is collaborating with @OpenAI to expand global access to clinical trials. 🌍 Through our collaboration with @OpenAI, we're enabling real-time trial parameterization and free pre-screening services in high-population regions, ensuring that life-changing opportunities are available to patients everywhere, not just those near major research centers. This is what AI-driven precision oncology looks like in practice: breaking down the barriers that have long kept underserved patients from accessing the trials that could change their lives. Read the full announcement → massivebio.com/massive-bio-e… #ClinicalTrials #AIinHealthcare #PrecisionOncology #HealthEquity #CancerResearch #OpenAI #DigitalHealth
2
2
6
1,702
Replying to @MassiveBio
@MassiveBio and @OpenAI are converting complex oncology and hematology eligibility criteria into structured parameters for real-time patient pre-screening. This collaboration targets one of BigPharma's enduring challenges ... matching patients to clinical trials quickly enough to affect treatment options. 🔗hlth.com/insights/news/massi… #NewMedsMatter
2
3
69
Massive Bio retweeted
OncoDaily
@oncodailyJan 12
Selin Kurnaz Recognized Among The 100 Most Influential CEOs in Oncology in 2025 @MassiveBio oncodaily.com/community/seli… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX
1
2
119
Really nice event by @FirstMarkCap where we had the chance to see a full @GoogleDeepMind demo and got to hang out with @amankabeer. Inspired to build even more at @MassiveBio . Thanks @mattturck and all your team, and @tyramp for hosting 👏 #AI #data
1
2
10
924
Day 3 #ASCO25 started with our #AI research showing fine tuned multi-agents plus an oncology knowledge graph was superior to frontier LLMs like 4o for data extraction and #clinicaltrial matching. Then a great plenary session with new treatments for our #cancer patients, learning exercise improves colon cancer survival, and meeting with esteemed colleagues passionate about uses of AI in cancer care. 👏 @ASCO | @mystlukes | @MassiveBio
3
16
694
Amazingly proud of the @MassiveBio team being bestowed the Wayfinder Award by the @PCCconsortium. Seven of the top pharmaceutical companies in the world recognizing our efforts in clinical trial matching and biomarker optimization for the betterment of cancer care is a real milestone. Proud and grateful 🚀 #ASCO25 #AI #clinicaltrials #cancerresearch
1
1
8
351
At the @ASCO Faculty Lounge checking my presentation for our ASCO / @myESMO session. Catching up with @dougflora2 and @therealoncdoc and talking about #AI is what makes this #ASCO25 so special. @mystlukes | @MassiveBio | @TempusAI |
2
8
375
Replying to @OpenMedKate @kaydaustin @MommyHasCancer
@AmericanCancer and @MassiveBio already deploying this at scale😀acts.cancer.org/

ACS ACTS: Finding the Right Clinical Trial for You

cancer.org
2
3
7
220
Flatiron Health, Massive Bio team up to optimise cancer trial enrollment @flatironhealth @MassiveBio #oncology #CancerResearch firstwordhealthtech.com/stor…

Flatiron Health, Massive Bio team up to optimise cancer trial enrollment

Flatiron Health announced on Monday that it has formed an alliance with Massive Bio to better identify patients with cancer who may be eligible for clinical trials and streamline enrollment across ...

firstwordhealthtech.com
1
3
116
#ASCO23 Look who's back 😉👍 @DrShubhamPant 🗣the update on adagrasib for Pts w/ KRASG12C-mutated cancers ➡️35% ORR across diseases ➡️21 PDAC and 12 biliary CA Pts enrolled with a 33% and 42% ORR respectively and with a PFS of 5.5 mos 👏Wonderful, but STILL room for improvement
3
24
2
57
7,657
Great times and views at the Navy Pier after such a productive day at #ASCO23 @MassiveBio @skurnaz
1
3
13
673
Day 1 #ASCO23 Highlights: 1. #NATALEE: Adj #ribociclib HR+ breast Ca 2. MONARCHE: Adj #abemaciclib update 3. #ATTRACTION5: Adj Gastric Ca 4. #IMbrave050: Adj HCC 5. OFS in Premenopausal 6. #IMerge imetelstat MDS @ASCO @OncoAlert #bcsm #gism #OncTwitter #MedTwitter 1/7
11
148
4
471
98,068
#ASCO23 @ASCO #LCSM CSS Combination chemotherapy with #gefintib #osimertinib ✨ started with G—>changed to O ✨ N=501, ex19 del or L858R ✨ mPFS 18mo, p=0.005 ✨ O arm mPFS 25.2 mo ✨ OS NOT better!! @EGFRResisters @OncoAlert @LungCancerRx
3
40
3
89
31,713
Embedded in @ErikaHamilton9 presentation is this critical pearl ➡️ adjuvant Abemaciclib benefit is maintained for ALL patients when dose modification is utilized💥 🔑dose modification for AE management is KEY! #ASCO23 @OncoAlert @OncBrothers
2
36
8
82
45,623
Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial Matching insideprecisionmedicine.com/… via @clinicalomics

Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial Matching

The Precision Cancer Consortium (PCC) has tapped Massive Bio and their AI analytics platform to optimize clinical trial matching.

insideprecisionmedicine.com
3
4
391
Good morning! In PJs for the @MSK_RadOnc faculty meeting this morning (camera off!) remotely from Chicago. Even though I’m at #ASCO23, always excited to hear what new technologies will be coming online and how our departmental initiatives fit into institutional priorities.
3
1
30
2,868
📢Historic news! @MassiveBio partners with @PCCconsortium, leveraging #AI to revolutionize clinical trial matching globally. Pioneering precision oncology to bring the right treatment to every cancer patient. 🎯🌍 #ASCO23 #MassiveBioPCC #PrecisionMedicine #NextGenOncology
Arturo LoAIza-Bonilla, MD MSEd
@DrArturoAI2 Jun 2023
Precision Cancer Consortium Teams Up with Massive Bio to Utilize AI Analytics and Enhance Clinical Trial Matching for Cancer Patients Worldwide - businesswire.com/news/home/2…

Precision Cancer Consortium Teams Up with Massive Bio to Utilize AI Analytics and Enhance Clinical...

Massive Bio, a leading artificial intelligence (AI) analytics company specializing in precision oncology, has been selected by the Precision Cancer Consortiu...

businesswire.com
3
6
536
Proud about @MassiveBio selection as one of the founding members of CancerX - we will have a press release on Sunday with more details, stay tuned at #ASCO23!! 💥 🚀 #AI #clinicaltrials #CancerResearch #CancerMoonshot #CancerX modernhealthcare.com/digital… via @modrnhealthcr @skurnaz
1
2
231
Load more